Slow deep breathing modulates cardiac vagal activity but does not affect peripheral glucose metabolism in healthy men.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 10 2021
Historique:
received: 25 03 2021
accepted: 23 08 2021
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 27 1 2022
Statut: epublish

Résumé

Parasympathetic nervous system innervates peripheral organs including pancreas, hepatic portal system, and gastrointestinal tract. It thereby contributes to the regulation of whole-body glucose metabolism especially in the postprandial state when it promotes secretion of insulin and enhances its action in major target organs. We now aimed to evaluate the effect of parasympathetic modulation on human glucose metabolism. We used slow deep breathing maneuvers to activate the parasympathetic nervous system and tested for effects on metabolism during an oral glucose tolerance test in a randomized, controlled, cross-over trial in 15 healthy young men. We used projections towards the heart as a readout for parasympathetic activity. When analyzing heart rate variability, there was a significant increase of RMSSD (root mean square of successive differences) when participants performed slow deep breathing compared to the control condition, indicating a modulation of parasympathetic activity. However, no statistically significant effects on peripheral glucose metabolism or energy expenditure after the glucose tolerance test were detected. Of note, we detected a significant association between mean heart rate and serum insulin and C-peptide concentrations. While we did not find major effects of slow deep breathing on glucose metabolism, our correlational results suggest a link between the autonomic nervous system and insulin secretion after oral glucose intake. Future studies need to unravel involved mechanisms and develop potential novel treatment approaches for impaired insulin secretion in diabetes.

Identifiants

pubmed: 34645853
doi: 10.1038/s41598-021-99183-2
pii: 10.1038/s41598-021-99183-2
pmc: PMC8514507
doi:

Substances chimiques

Blood Glucose 0
C-Peptide 0
Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20306

Informations de copyright

© 2021. The Author(s).

Références

Indian J Med Res. 2004 Aug;120(2):115-21
pubmed: 15347862
Clin Exp Hypertens. 2001 Jan-Feb;23(1-2):45-55
pubmed: 11270588
Acta Diabetol. 2016 Dec;53(6):1037-1044
pubmed: 27771766
Am J Clin Nutr. 2013 Apr;97(4):763-73
pubmed: 23446893
Adv Physiol Educ. 2013 Mar;37(1):53-60
pubmed: 23471249
Diabetes. 2014 Dec;63(12):4083-8
pubmed: 25028522
Diabetologia. 2010 Jul;53(7):1270-87
pubmed: 20361178
Rev Endocr Metab Disord. 2014 Mar;15(1):67-77
pubmed: 24174131
Horm Metab Res. 1993 Oct;25(10):507-12
pubmed: 8262457
Diabetes. 2009 Apr;58(4):773-95
pubmed: 19336687
Anesth Analg. 1994 Aug;79(2):373-7
pubmed: 7639382
J Cardiovasc Electrophysiol. 1999 Sep;10(9):1192-9
pubmed: 10517651
Nature. 2006 Sep 21;443(7109):289-95
pubmed: 16988703
Diabet Med. 2003 May;20(5):399-405
pubmed: 12752490
Psychophysiology. 2019 Nov;56(11):e13447
pubmed: 31361032
Gastroenterology. 2021 Feb;160(3):875-888.e11
pubmed: 33121946
Behav Res Methods. 2011 Dec;43(4):1161-70
pubmed: 21573720
Psychosom Med. 2018 Jul/Aug;80(6):581-587
pubmed: 29771730
Front Physiol. 2013 Aug 26;4:222
pubmed: 23986716
Int J Sports Med. 1999 May;20(4):232-8
pubmed: 10376479
Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H640-7
pubmed: 16172170
Endocr Rev. 2009 Oct;30(6):557-85
pubmed: 19749172
Hypertens Res. 2005 Jun;28(6):499-504
pubmed: 16231755
Diabetes. 2001 May;50(5):1030-8
pubmed: 11334405
JPEN J Parenter Enteral Nutr. 2008 Sep-Oct;32(5):569-71
pubmed: 18753395
Exp Psychol. 2010;57(1):36-45
pubmed: 20178962
Diabetologia. 2003 Jan;46(1):3-19
pubmed: 12637977
Sci Rep. 2020 Nov 24;10(1):20466
pubmed: 33235256

Auteurs

Andreas Vosseler (A)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Dongxing Zhao (D)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.

Julia Hummel (J)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Ali Gholamrezaei (A)

Pain Management Research Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Sarah Hudak (S)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Konstantinos Kantartzis (K)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Andreas Peter (A)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.

Andreas L Birkenfeld (AL)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Hans-Ulrich Häring (HU)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Robert Wagner (R)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Hubert Preißl (H)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Stephanie Kullmann (S)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Martin Heni (M)

Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal Medicine IV, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany. martin.heni@med.uni-tuebingen.de.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany. martin.heni@med.uni-tuebingen.de.
German Center for Diabetes Research (DZD), Neuherberg, Germany. martin.heni@med.uni-tuebingen.de.
Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany. martin.heni@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH